Evidence map›Paper›PMID 39605647›Full record

ArticlebioRxiv : the preprint server for biology2024

IL-33 protects from recurrent

Farha Naz, Nicholas Hagspiel, Mary K Young, Jashim Uddin, David Tyus, Rachel Boone, Audrey C Brown, Girija Ramakrishnan, Isaura Rigo, Gregory R Madden and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Farha NazDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
Nicholas HagspielDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
Mary K YoungDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
Jashim UddinDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
David TyusDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
Rachel BooneDepartment of Microbiology, Immunology and Cancer Biology, Charlottesville, Virginia, USA.
Audrey C BrownDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
Girija RamakrishnanDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
Isaura RigoDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
Gregory R MaddenDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.
William A PetriDepartment of Medicine, Division of Infectious Diseases and International Health, Charlottesville, Virginia, USA.

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
Role of Th17 in Severe and Recurrent C. difficile InfectionR01AI152477 · NIAID · UNIVERSITY OF VIRGINIA · PI PETRI, WILLIAM A, RAMAKRISHNAN, GIRIJA · 2020 to 2025
$7.1M
Role of Type 2 Immunity in Innate Protection from C. difficileR01AI124214 · NIAID · UNIVERSITY OF VIRGINIA · PI William A Petri · 2016 to 2026
$5.4M
NIAID NIH HHS R01 AI124214NIAID NIH HHS R01 AI152477NIAID NIH HHS T32 AI007046
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clostridioides difficiledysbiosisGC-TFHIL-33 signalingILC2srecurrent C. difficile infectionTH17 cellstoxin-specific antibody

Identifiers

PMID39605647
PMCPMC11601440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.